Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells

Current Opinion in Nephrology and Hypertension

Volumn 12, Issue 1, 2003, Pages 25-29

  Lan, Hui Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; Fibroblast growth factor; Smad signaling; Transforming growth factor ; Tubular epithelial myofibroblast transdifferentiation

Indexed keywords

ACTIN; ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; SCATTER FACTOR; SMAD PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; DOWN REGULATION; GLOMERULONEPHRITIS; HUMAN; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; MESENCHYME; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPINDLE CELL; STRESS FIBER;

ACTINS; ANIMALS; BASEMENT MEMBRANE; CADHERINS; CELL DIFFERENTIATION; FIBROBLASTS; HUMANS; KIDNEY TUBULES, PROXIMAL; NEPHRITIS, INTERSTITIAL;

EID: 0037229290     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200301000-00005     Document Type: Review

References (33)

1. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7:2495-2508.
2. Goumenos DS, Brown CB, Shortland J, El Nahas AM. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 1992; 9:1418-1425.
3. Roberts IS, Burrows C, Shanks JH, et al. Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol 1997; 50:123-127.
4. Hewitson TD, Wu HL, Becker GJ, Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 1995; 15:411-417.
5. Masur SK, Dewal HS, Dinh TT, et al. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci USA 1996; 93:4219-4223.
6. Yang N, Wu LL, Nickolic-Paterson DJ, et al. Local macrophage and myofibroblast proliferation in 5/6 nephretomised rat model. Nephrol Dial Transplant 1998; 13:1967-1974.
7. Hay ED, Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995; 26:678-690.
8. Strutz F, Okada H, Lo CW, et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130:393-405.
9. Ng YY, Huang TP, Yang WC, et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998; 54:864-876
10. Holthofer H, Miettinen A, Lehto VP, et al. Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest 1984; 50:552-559.
11. Wallin A, Zhang G, Jones TW, et al. Mechanism of the nephrogenic repair response: studies on proliferation and vimentin expression after 35S-1,2-dichlorovinyl-L-cysteine nephrotoxicity in vivo and in cultured proximal tubule epithelial cells. Lab invest 1992; 66:474-484.
12. Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney: evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994; 93:2175-2188.
13. Frazier KS, Paredes A, Dube P, Styer E. Connective tissue growth factor expression in the rat remnant kidney model and association with tubular epithelial cells undergoing transdifferentiation. Vet Pathol 2000; 37:328-335.
14. Ng YY, Fan J-M, Mu W, et al. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 1999; 14:2860-2872.
15. Jinde K, Nikolic-Paterson DJ, Huang XR, et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 2001; 38:761-769. This exciting study provides the first evidence for TEMT in progressive tubulointerstitial fibrosis in human glomerulonephritis and demonstrates that the transformed TECs with co-expression of cytokeratin and α-SMA are co-localized with upregulation of TGF-β and FGF-2 and collagen matrix production.
16. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001; 159:1465-1475. This study dissects the process of TEMT involved in four key steps, including loss of epithelial phenotype, expression of α-SMA, destruction of TBM, and enhanced migration and invasion.
17. Fan JM, Ng YY, Hill PA, et al. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999; 56:1455-1467.
18. Fan JM, Huang XR, Ng YY, et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta 1-dependent mechanism in vitro. Am J Kidney Dis 2001; 37:820-831. This study identifies that interleukin-1 can induce TEMP via the TGF-β-dependent mechanism cells and describes the process of TEMP involving a loss of E-cadherin and de-novo expression of α-SMA in NRK52E.
19. Yang J, Lui Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002; 13:96-107. This study demonstrates that TGF-β-induced TEMT is inhibited by the addition of HGF both in vitro and in vivo, indicating that HGF is capable of counter-regulating TGF-β-induced TEMT.
20. Bush KT, Tsukamoto T, Nigam SK. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am J Physiol 2000; 278:F847-F852.
21. Riethmacher D, Brinkmann V, Birchmeier C. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc Natl Acad Sci USA 1995; 92:855-859.
22. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2:76-83.
23. Zeisberg M, Bonner G, Maeshima Y, et al. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 2001; 159:1313-1321. This study describes the importance of TBM in the maintenance of epithelial phenotype and the critical role of TBM compositions in TGF-β and EMT in vitro.
24. Strutz F, Zeisberg M, Ziyadeh FN, et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002; 61:1714-1728. This study demonstrates that FGF-2, like TGF-β, induces fibroblast-specific protein-1 and vimentin expression, but inhibits cytokeratin expression. The induction of matrix metalloproteinase-2 and 9 expression by FGF-2 indicates that FGF-2 makes an important contribution to EMT in vitro.
25. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000; 11:574-581.
26. Oldfield MD, Bach LA, Forbes JM, et al. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001; 108:1853-1863. This exciting study provides the first evidence that AGEs are able to induce TEMT via the receptor for advanced glycation end products-mediated, TGF-β-dependent mechanism in vitro, indicating that TEMT may play a pathogenic role in diabetic nephropathy.
27. Huang XR, Li JH, Chen YX, et al. SMAD signaling, a novel pathway of angiotensin II-induced renal fibrosis. J Am Soc Nephrol 2001; 12:465.
28. Li JH, Zhu HJ, Huang XR, et al. Smad7 inhibits fibrotic effect of tgf-Beta on renal tubular epithelial cells by blocking smad2 activation. J Am Soc Nephrol 2002; 13:1464-1472. This important study delineates the intracellular signaling pathway whereby TGF-β induces TEMT in vitro. TGF-β signals through Smad2 to mediate TEMT and collagen matrix production, which is blocked by overexpression of the inhibitory Smad7, indicating that Smad signaling plays a key role in TEMT.
29. Kretzschmar M, Massague J. Smads: mediators and regulators of TGF-β signaling. Curr Opin Genet Dev 1998; 8:103-111.
30. Zimmerman CM, Padgett RW. Transforming growth factor B signaling mediators and regulators. Gene 2000; 249:17-30.
31. Nakao A, Afrakhte M, Moren A, et al. Identification of Smad7, a TGF beta-inducible antagonist of TGF-beta signaling. Nature 1997; 389:631-635.
32. Itoh S, Landström M, Hermansson A, et al. Transforming growth factor-β1 induces nuclear export of inhibitory Smad7. J Biol Chem 1998; 44:29195-29201.
33. Kavsak P, Rasmussen RK, Causing CG, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 2000; 6:1365-1375.